Back to search
FDAFDA · Food and drugs·Recall number D-0420-2018

Atorvastatin Calcium Tablets 40 mg, 90 count bottles, Rx only, Mfd by: Dr. Reddy's Laboratories, Ltd., Srikakulam, INDIA --- NDC 55111-123-05

Published February 7, 2018 · Recall initiated: January 29, 2018

Summary

FDA records drug Class III recall D-0420-2018, published February 7, 2018 and initiated January 29, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 12,579 bottles; Lot: Lot number: T600279, 6/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability

What to do

Voluntary: Firm initiated · Letter

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide
UPC
0355111123903
Lot
Lot number: T600279, 6/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvastatin Calcium Tablets 40 mg, 90 count bottles, Rx only, Mfd by: Dr. Reddy's Laboratories, Ltd., Srikakulam, INDIA --- NDC 55111-123-05 recalled?

Yes. FDA published recall D-0420-2018 on February 7, 2018. Reported hazard: Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0355111123903.